BioArctic AB (publ)

kr 307.20As of Sun 8 Nov 2026, 12:00 UTC
STO:BIOA-BHealthcare
Country Sweden
PE (Fwd) •••
TSR 9Y CAGR 32.32%
Div yield 0.65%
ROE 5.21%
Biotechnology
Beta (5Y) (0.63)
PE TTM 259.4
TSR TTM 5.54%
Mkt cap kr 27.26B
ROIC 52.02%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 359
16.85%
(39.44%)
Hold 6|8|5|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
4.43
4.41
4.29
4.55
(3.14%)
(0.69%)
(2.24%)
3.16%
Revenuekr B
1.321
1.300
1.294
1.315
(1.49%)
(3.37%)
(1.41%)
(2.62%)
Peers (US$2.756B)
Cap (US$)
PE
4.398B
58.11x
Capital
TTM
5Y
10Y
Leveragex
4.627
0.363
0.306
EBIT/Intx
0.186
0.151
0.120
Own earn%
67.21
(53.47)
(67.59)
Sh yield%
43.77
30.93
30.41
Owners
Insiders/Inst%
10.10
88.79
Short interest%
4.67
SBC / revenue%
2.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
29–36
$1 testx
—
Incr. ROIC%
2